Call for Abstract

13th World Congress on Cell and Stem Cell Research, will be organized around the theme “”

STEMCELL CONFERENCE 2021 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in STEMCELL CONFERENCE 2021

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Cell Based Therapy In Veterinary Medicine
  • Track 1-2Bio Science And Clinical Applications of Stem Cells In Veterinary Medicine
  • Track 1-3Stem Cells And Regeneration In Veterinary Science
  • Track 2-1Types of Gene Therapy
  • Track 2-2Gene Therapy Techniques
  • Track 2-3Gene Therapy Challenges
  • Track 3-1Ethical Issues In Stem Cell Research
  • Track 3-2Key Ethical Issues In Embryonic Stem Cell
  • Track 3-3IPR
  • Track 3-4Biosafety And RDNA Guidelines
  • Track 3-5Governing Stem Cell Therapy And Fundings
  • Track 5-1Somatic Cell Nuclear Transfer (SCNT)
  • Track 5-2Gene Therapy and Genetic Engineering
  • Track 5-3Somatic Gene Therapy
  • Track 5-4Germ Line Gene Therapy
  • Track 5-5Cell Cancer Immunotherapy

Cell signaling is part of any communication process that governs basic activities of cells and coordinates all cell actions. The ability of cells to perceive and correctly respond to their microenvironment is the basis of development, tissue repair, and immunity, as well as normal tissue homeostasis. Errors in signaling interactions and cellular information processing are responsible for diseases such as cancer, autoimmunity, and diabetes. By understanding cell signaling, diseases may be treated more effectively and, theoretically, artificial tissues may be created.

  • Track 6-1Crosstalk
  • Track 6-2Cell Signaling Dynamics
  • Track 6-3Modern Approach in Cell Signaling
  • Track 6-4Cell Adhesion and Cell Communication
  • Track 6-5Immune Signaling

Stem cells: An undifferentiated cell of a multicellular organism which is capable of giving rise to indefinitely more cells of the same type, and from which certain other kinds of cell arise by differentiation. Stem cells have the ability to differentiate into specific cell types. The two defining characteristics of a stem cell are perpetual self-renewal and the ability to differentiate into a specialized adult cell type. There are two major classes of stem cells: pluripotent that can become any cell in the adult body, and multipotent that are restricted to becoming a more limited population of cells.

  • Track 7-1Embryonic stem cells
  • Track 7-2Non-embryonic (adult) stem cells
  • Track 7-3Induced pluripotent stem cells (iPSCs)
  • Track 7-4Cord blood stem cells and amniotic fluid stem cells
  • Track 7-5Tissue Stem Cells

The study of changes in organisms caused by modification of gene expression rather than alteration of the genetic code itself. Epigenetics are stable heritable traits  that cannot be explained by changes in DNA sequence.

  • Track 8-1Bone Remodeling And Osteoporosis
  • Track 8-2Single-cell Technology In Cancer Research
  • Track 8-3Stem Cell Epigenetics And Disease
  • Track 8-4Epigenetic regulation of stem cells differentiating

A stem-cell niche is an area of a tissue that provides a specific microenvironment, in which stem cells are present in an undifferentiated and self-renewable state. Cells of the stem-cell niche interact with the stem cells to maintain them or promote their differentiation. The general niche model involves the association between resident stem cells and heterologous cell types—the niche cells.


Stem Cell Banking is a facility that preserves stem cells derived from amniotic fluid for future use. Stem cell samples in private or family banks are preserved precisely for use by the individual person from whom such cells have been collected and the banking costs are paid by such person. The sample can later be retrieved only by that individual and for the use by such individual or, in many cases, by his or her first-degree blood relatives.



  • Track 9-1Amniotic Stem Cell Bank
  • Track 9-2Umbilical Cord Blood Banks
  • Track 9-3Hematopoietic Stem Cell And Potential Non-Hematopoietic Stem Cells
  • Track 9-4Invivo & Invitro Stem cell Microenvironment
  • Track 9-5Cancer Stem Cell Niche
  • Track 9-6Extracellular Matrix Mimicking strategies for Stem cell Niche

Self-reestablishment and multiplication of foundational microorganism populaces is controlled, to some degree, by affectation of apoptosis. The quantity of foundational microorganisms is thusly a harmony between those lost to separation/apoptosis and those increased through multiplication. Apoptosis of immature microorganisms is accepted to be a dynamic procedure which changes because of natural conditions.


  • Track 10-1Genomic Analysis And Molecular Basis of Cancer
  • Track 10-2Cancer Stem Cells And Impaired Apoptosis
  • Track 10-3Inflammatory Diseases And Cancer
  • Track 10-4Epigenetics And Cancer Stem Cells
  • Track 10-5Apoptosis And Haematopoietic Stem Cells

Embryonic stem (ES) cells are cells derived from the early embryo that can be propagated indefinitely in the primitive undifferentiated state while remaining pluripotent; they share these properties with embryonic germ (EG) cells. Candidate Embryonic stem and embryonic germ cell lines from the human blastocyst and embryonic gonad can differentiate into multiple types of somatic cell.


  • Track 11-1Molecular Alterations During Female Reproductive Aging
  • Track 11-2Role of Sperm DNA Integrity In Fertility
  • Track 11-3Fertilization And Infertility
  • Track 11-4Embryo Implantation
  • Track 11-5Role of Macrophages In The Placenta
  • Track 11-6Factors of Human Implantation
  • Track 11-7Stimulus Trigerred Acquisition of Pluripotency (STAP)
  • Track 11-8Stimulus Trigerred Acquisition of Pluripotency (STAP)

Stem cell therapy is a type of cell therapy in which therapeutic efficacy exclusively attributed to the potency (function) of donor stem cells, presented in any quantity and purity. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.

  • Track 12-1Allogenic cell therapy
  • Track 12-2Human embryonic stem Cells
  • Track 12-3Neural stem cell Therapy
  • Track 12-4Messenchymal stem cell therapy
  • Track 12-5Haematopoietic stem cell transplantation
  • Track 12-6Specific Cancer Immunotherapy
  • Track 12-7Translational Studies For Cancer Stem Cell-Based Therapies
  • Track 12-8Ubiquitination Pathways For Cancer Therapy
  • Track 12-9Enantioselectivity And Chiral Complexing In Cancer Therapy

Stem Cell Biomarker is characterized as a quality or their proteins that are utilized to disengage and recognize immature microorganisms. The other approach to distinguish the undifferentiated organisms is by utilizing utilitarian assays. Molecular biomarkers serve as profitable apparatuses to arrange and segregate embryonic immature microorganisms (ESCs) and to screen their separation state by immunizer based systems. ESCs can offer ascent to any grown-up cell sort and in this way offer colossal potential for regenerative medication and drug revelation. Various biomarkers, for example, certain cell surface antigens, are utilized to dole out pluripotent ESCs

  • Track 13-1Stem Cell Markers
  • Track 13-2Biomarkers And Cancers
  • Track 13-3Organ Cancer: Pancreatic Cancer, Colorectal Cancer, Breast , Oral, Head And Neck Cancer.
  • Track 13-4Cancer Therapeutics

Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition.The most well-established and widely used stem cell treatment is the transplantation of blood stem cells to treat diseases and conditions of the blood and immune system, or to restore the blood system after treatments for specific cancers.


  • Track 14-1Autoimmune Disease Stem Cell Treatment
  • Track 14-2Blood And Skin Diseases
  • Track 14-3Organ Cancer: Gastric cancer, Breast, Oral, Head And Neck Cancer
  • Track 14-4Lymphoma
  • Track 14-5Alzheimers And Stem Cells
  • Track 14-6Periodontal Diseases And Stem Cells
  • Track 15-1Protection of human stem cells
  • Track 15-2Stem cell and insulin
  • Track 15-3Hematopoietic malignancies
  • Track 15-4Immune cells regulate blood stem cells

Stem cell transplantation, sometimes referred to as bone marrow transplant, is a procedure that replaces unhealthy blood-forming cells with healthy cells. Stem cell transplants commonly are used to treat Leukemia and lymphoma, cancers that affect the blood and lymphatic system.


  • Track 16-1Allogeneic Bone marrow Transplantation
  • Track 16-2Hematopoietic Stem Cell Transplantation
  • Track 16-3Epithelial Transplantation
  • Track 16-4Haploidentical Stem Cell Transplantation
  • Track 16-5Transplantation In Primary Immunodeficiency
  • Track 16-6Retinal Stem Cell Transplantation
  • Track 16-7Myelodysplastic syndrome and drug therapy
  • Track 16-8Challenges in Transplanting Stem Cells

Tissue engineering can be defined as the use of a combination of cells, engineering materials, and suitable biochemical factors to improve or replace biological functions in an effort to improve clinica l procedures for the repair of damaged tissues and organs.

  • Track 17-1Trends & Applications In Tissue Engineering
  • Track 17-2Scaffolds In Regenerative Medicine
  • Track 17-3Tissue Repair And Regeneration
  • Track 17-4Stem Cells Progress In In situ Revascularization And Grafting
  • Track 17-5Regeneration Manufacturing Challenges for Regenerative Medicine

A disease model is an animal or cells displaying all or some of the pathological processes that are observed in the actual human or animal disease. Studying disease models aids understanding of how the disease develops and testing potential treatment approaches.


  • Track 19-1Astrocyte Differentiation And Stem Cells
  • Track 19-2Modeling Human Disease With Pluripotent Stem Cells
  • Track 19-3Adult Stem cells And Embryonic Stem Cells In Disease Modelling
  • Track 19-4Induced Pluripotent Stem Cells Greatest Utility For Disease Modelling
  • Track 19-5Stem Cell Role In Toxicity Testing
  • Track 19-6Loaded Polymeric Nanoparticles Stem Cells
  • Track 19-7Autologus MSCs In Veterinary Applications
  • Track 19-8Computational Tools for Stem Cell Biology

Cancer cells are cells gone wrong  in other words, they no longer respond to many of the signals that control cellular growth and death. Cancer cells originate within tissues and, as they grow and divide, they diverge ever further from normalcy. Over time, these cells become increasingly resistant to the controls that maintain normal tissue and as a result, they divide more rapidly than their progenitors and become less dependent on signals from other cells. Cancer cells even evade programmed cell death, despite the fact that their multiple abnormalities would normally make them prime targets for apoptosis. In the late stages of cancer, cells break through normal tissue boundaries and metastasize to new sites in the body

  • Track 20-1Therapeutic Target For Cancer
  • Track 20-2Hormone Therapies
  • Track 20-3Histology
  • Track 20-4Pathology
  • Track 20-5Cancer Stem Cells And Drug Resistance
  • Track 21-1Nanotechnology In The Regeneration of Complex Tissues
  • Track 21-2Regenerative Approaches With Nanoparticles

Stem cell plasticity refers to the ability of some stem cells to give rise to cell types, formerly considered outside their normal repertoire of differentiation for the location where they are found. Included under this umbrella title is often the process of “transdifferentiation” – the conversion of one differentiated cell type into another, and metaplasia – the conversion of one tissue type into another.


  • Track 22-1Epithelial To Mesenchymal Plasticity And Stem Cells
  • Track 22-2Tissue Repair
  • Track 22-3Mechanism of Cellular Plasticity
  • Track 22-4Adaptive Cellular Reprogramming

Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the "process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function.

  • Track 23-1Regenerative Approaches With Nanoparticles
  • Track 23-2Decellularization
  • Track 23-3Blastocyst Complementation
  • Track 23-4Reprogramming And Creating Stem Cells
  • Track 23-5Advanced Developments In Artificial Organ System